UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (787) 787
cefoxitin - therapeutic use (714) 714
female (529) 529
adult (393) 393
male (391) 391
middle aged (322) 322
science & technology (269) 269
life sciences & biomedicine (245) 245
aged (227) 227
biological and medical sciences (214) 214
medical sciences (212) 212
bacterial infections - drug therapy (202) 202
cefoxitin (188) 188
abridged index medicus (184) 184
pharmacology. drug treatments (172) 172
cefoxitin - administration & dosage (159) 159
cefoxitin - pharmacology (155) 155
antibiotics. antiinfectious agents. antiparasitic agents (154) 154
surgical wound infection - prevention & control (152) 152
anti-bacterial agents - therapeutic use (149) 149
antibacterial agents (148) 148
clinical trials as topic (148) 148
premedication (145) 145
antibiotics (142) 142
adolescent (139) 139
microbial sensitivity tests (138) 138
cefoxitin - adverse effects (134) 134
prospective studies (132) 132
random allocation (129) 129
infectious diseases (127) 127
microbiology (118) 118
animals (115) 115
cephalosporins - therapeutic use (109) 109
anti-bacterial agents - pharmacology (98) 98
pharmacology & pharmacy (91) 91
pregnancy (87) 87
drug resistance (83) 83
bacteria (80) 80
drug evaluation (80) 80
drug therapy, combination (80) 80
drug resistance, microbial (78) 78
double-blind method (74) 74
child (69) 69
infections (69) 69
research article (69) 69
postoperative complications - prevention & control (66) 66
bacterial infections - prevention & control (65) 65
cephamycins - therapeutic use (64) 64
antimicrobial agents (61) 61
bacteria - drug effects (59) 59
bacterial infections - microbiology (56) 56
clindamycin - therapeutic use (49) 49
ampicillin - therapeutic use (48) 48
biochemical phenomena, metabolism, and nutrition (48) 48
drug therapy, combination - therapeutic use (48) 48
gentamicins - therapeutic use (48) 48
ampicillin (46) 46
cefamandole - therapeutic use (46) 46
cefoxitin - metabolism (46) 46
penicillin (45) 45
polycyclic compounds (44) 44
staphylococcus infections (43) 43
laboratories (42) 42
bacterial infections and mycoses (41) 41
cesarean section (41) 41
child, preschool (41) 41
metronidazole - therapeutic use (41) 41
acute disease (40) 40
antimicrobial resistance (40) 40
bacterial diseases (40) 40
escherichia coli infections - drug therapy (40) 40
mice (40) 40
urinary tract infections - drug therapy (40) 40
cefotaxime - therapeutic use (39) 39
cefotetan - therapeutic use (39) 39
e coli (39) 39
time factors (39) 39
infant (38) 38
antibiotic prophylaxis (37) 37
escherichia coli - drug effects (37) 37
pelvic inflammatory disease - drug therapy (37) 37
cephalosporins (36) 36
cefazolin - therapeutic use (35) 35
cephalosporins - pharmacology (35) 35
drug resistance in microorganisms (35) 35
antibiotic resistance (34) 34
pathogens (34) 34
aged, 80 and over (33) 33
cefotetan (33) 33
hospitals (33) 33
hysterectomy (33) 33
kinetics (33) 33
methicillin (33) 33
risk factors (33) 33
staphylococcus aureus (33) 33
bacterial proteins - genetics (32) 32
surgery (32) 32
cefoxitin - blood (31) 31
injections, intravenous (31) 31
medicine (31) 31
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (843) 843
Japanese (62) 62
Italian (34) 34
German (32) 32
French (21) 21
Spanish (14) 14
Portuguese (6) 6
Chinese (3) 3
Czech (3) 3
Bulgarian (2) 2
Russian (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American journal of respiratory and critical care medicine, ISSN 1073-449X, 11/2009, Volume 180, Issue 9, pp. 896 - 902
Treatment outcome | Lung diseases | Mycobacterium abscessus | Atypical mycobacteria | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy | Pharmacology. Drug treatments | Biological and medical sciences | Intensive care medicine | Medical sciences | Antibacterial agents | Antibiotics. Antiinfectious agents. Antiparasitic agents | Sputum - microbiology | Lung - microbiology | Cefoxitin - therapeutic use | Lung Diseases - microbiology | Humans | Middle Aged | Male | Tomography, X-Ray Computed | Lung - diagnostic imaging | Lung Diseases - drug therapy | Anti-Bacterial Agents - therapeutic use | Sputum - drug effects | Liver - drug effects | Mycobacterium Infections, Nontuberculous - microbiology | Adult | Female | Anti-Bacterial Agents - adverse effects | Retrospective Studies | Drug Therapy, Combination | Neutropenia - chemically induced | Chemical and Drug Induced Liver Injury - etiology | Doxycycline - adverse effects | Ciprofloxacin - adverse effects | Nontuberculous Mycobacteria - drug effects | Clarithromycin - adverse effects | Doxycycline - therapeutic use | Ciprofloxacin - therapeutic use | Anti-Infective Agents - therapeutic use | Treatment Outcome | Clarithromycin - therapeutic use | Thrombocytopenia - chemically induced | Nontuberculous Mycobacteria - isolation & purification | Amikacin - adverse effects | Amikacin - therapeutic use | Lung - drug effects | Cefoxitin - adverse effects | Mycobacterium Infections, Nontuberculous - drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Molecules (Basel, Switzerland), ISSN 1420-3049, 12/2019, Volume 24, Issue 24, p. 4511
Journal Article
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 03/2012, Volume 56, Issue 3, pp. 1376 - 1381
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Urinary tract. Prostate gland | Infectious diseases | Bacterial diseases | Human bacterial diseases | Urinary system involvement in other diseases. Miscellaneous | Pharmacology. Drug treatments | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Bacterial diseases of the urinary system | Antibiotics. Antiinfectious agents. Antiparasitic agents | Conjugation, Genetic | Imipenem - therapeutic use | Cefoxitin - therapeutic use | Carbapenems - administration & dosage | Escherichia coli - drug effects | Humans | Ceftriaxone - pharmacology | Bacterial Load - drug effects | Cefoxitin - pharmacology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Carbapenems - pharmacology | beta-Lactamases - genetics | Ceftriaxone - administration & dosage | Female | Urinary Tract Infections - microbiology | Urinary Bladder - microbiology | beta-Lactamases - metabolism | Disease Models, Animal | Escherichia coli Infections - drug therapy | Imipenem - administration & dosage | Kidney - drug effects | Cefoxitin - administration & dosage | Drug Administration Schedule | Escherichia coli Infections - microbiology | Mutation Rate | Imipenem - pharmacology | Urinary Tract Infections - drug therapy | Kidney - microbiology | beta-Lactams - pharmacology | Animals | Ceftriaxone - therapeutic use | Carbapenems - therapeutic use | Escherichia coli - genetics | Plasmids | Urinary Bladder - drug effects | Anti-Bacterial Agents - pharmacology | Mice | beta-Lactams - therapeutic use | Anti-Bacterial Agents - administration & dosage | beta-Lactams - administration & dosage | Index Medicus | Experimental Therapeutics
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 5/2014, Volume 58, Issue 9, pp. 1287 - 1296
Journal Article
Journal Article